G01N 2333/55
Il-2
G01N2333/55 (Il-2) appears on 71 US grants and 152 published applications in this corpus.
Search patents in G01N- Granted patents
- 71
- Published applications
- 152
- Assignees
- 107
- Inventors
- 305
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 4 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 2 | 4 |
| 2010 | 0 | 5 |
| 2011 | 3 | 5 |
| 2012 | 0 | 3 |
| 2013 | 3 | 7 |
| 2014 | 4 | 7 |
| 2015 | 8 | 11 |
| 2016 | 3 | 11 |
| 2017 | 5 | 16 |
| 2018 | 13 | 8 |
| 2019 | 2 | 5 |
| 2020 | 5 | 10 |
| 2021 | 3 | 8 |
| 2022 | 4 | 9 |
| 2023 | 2 | 8 |
| 2024 | 2 | 7 |
| 2025 | 4 | 10 |
| 2026 | 2 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cytokine-based therapies and methods30 Jun 2026US 12,668,627 B2Reverb Therapeutics, Inc.
- Method for measuring systemic chronic inflammaging6 Jan 2026US 12,517,135 B2Edifice Health, Inc.
- Biomarker panels for on-treatment prediction of response to immuno-oncology drugs30 Sep 2025US 12,429,485 B2The Brigham and Women S Hospital, Inc.
- Methods for treating and reducing traumatic brain injury-associated impairments using SGP13026 Aug 2025US 12,397,040 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- De novo design of potent and selective interleukin mimetics4 Mar 2025US 12,240,880 B2The Board of Trustees of the Leland Stanford Junior University
- Novel cytokine-based therapies and methods17 Sep 2026US 2026/0274943 A1Reverb Therapeutics, Inc.
- Affinity and functional based screening of t cell receptor repertoire using three-dimensional shaped particles30 Jul 2026US 2026/0218282 A1The Regents of the University of California
- An improved assay method for determining the potency of recombinant protein18 Jun 2026US 2026/0169007 A1Kashiv Biosciences, LLC
- Methods for Diagnosing and Treating Vestibular Schwannoma21 May 2026US 2026/0140117 A1The Board of Trustees of the Leland Stanford Junior University
- Therapeutic polynucleotides encoding t cell receptor (tcr) alpha chain polypeptides and/or tcr beta chain polypeptides29 Jan 2026US 2026/0027153 A1The Regents of the University of California
Most cited
By later US patents
- Antibodies to human programmed death receptor PD-1454US 8,354,509 B2MSD Oss B.V. · 2013
- Protein detection via nanoreporters166US 9,714,937 B2NanoString Technologies, Inc. · 2017
- Antibodies to human programmed death receptor PD-1151US 8,900,587 B2Merck Sharp & Dohme Corp. · 2014
- Antibodies to human programmed death receptor PD-1107US 8,952,136 B2Merck Sharp & Dohme Corp. · 2015
- Mutant interleukin-2 (IL-2) polypeptides67US 7,569,215 B2Massachusetts Institute of Technology · 2009